EGFR targeting for cancer therapy: Pharmacology and immunoconjugates with drugs and nanoparticles-Reference-Cited by-同舟云学术

EGFR targeting for cancer therapy: Pharmacology and immunoconjugates with drugs and nanoparticles

Published:2021-01 Issue: Volume:592 Page:120082
ISSN:0378-5173
Container-title:International Journal of Pharmaceutics
language:en
Short-container-title:International Journal of Pharmaceutics

Author:

Santos Elias da Silva,Nogueira Karina Alexandre Barros,Fernandes Luiziana Cavalcante Costa,Martins Jéssica Roberta Pereira,Reis Alice Vitoria Frota,Neto José de Brito Vieira,Júnior Ivanildo José da Silva,Pessoa Claudia,Petrilli Raquel^ORCID,Eloy Josimar O.

Funder

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference159 articles.

1. Nano-therapeutics for modulating the tumour microenvironment: design, development, and clinical translation;Adityan;J. Control. Release,2020

2. Gemcitabine-loaded PLGA-PEG immunonanoparticles for targeted chemotherapy of pancreatic cancer;Aggarwal;Cancer Nanotechnol.,2013

3. EGFR targeted PLGA nanoparticles using gemcitabine for treatment of pancreatic cancer;Aggarwal;J. Biomed. Nanotechnol.,2011

4. Iron oxide nanoparticles for therapeutic applications;Alphandéry;Drug Discov. Today,2020

5. In-depth biophysical analysis of interactions between therapeutic antibodies and the extracellular domain of the epidermal growth factor receptor;Alvarenga;Anal. Biochem.,2012

Cited by 112 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting EGFR with molecular degraders as a promising strategy to overcome resistance to EGFR inhibitors;Future Medicinal Chemistry;2024-08-29

2. Toxicity Profile of eBAT, a Bispecific Ligand-Targeted Toxin Directed to EGFR and uPAR, in Mice and a Clinical Dog Model;Toxins;2024-08-26

3. The Role of Inhaled Chitosan-Based Nanoparticles in Lung Cancer Therapy;Pharmaceutics;2024-07-23

4. Natural compounds-based nanomedicines for cancer treatment: Future directions and challenges;Drug Delivery and Translational Research;2024-07-13

5. The challenges and breakthroughs in the development of diagnostic monoclonal antibodies;VIEW;2024-06-25